We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Learn about RSV in children: symptoms, risks, diagnosis, treatment, and prevention. Expert advice for parents to keep their little ones safe during RSV season.

Respiratory Syncytial Virus (RSV) is a common respiratory virus that can affect people of all ages. While it often presents as a mild, cold-like illness, it can lead to more severe complications, particularly in infants, young children, older adults, and individuals with certain underlying health conditions. In India, like in many parts of the world, RSV is a significant cause of respiratory infections in children, especially during the cooler months. Understanding RSV, its symptoms, and how to protect your little ones is crucial for parents and caregivers.
In recent years, there has been a noticeable surge in RSV cases. Experts suggest that this surge is partly due to the lifting of COVID-19 mitigation measures such as mask-wearing and social distancing. During the pandemic, these measures helped reduce the spread of not only COVID-19 but also other respiratory viruses like RSV. As communities reopened and children returned to schools and public places, the virus found more opportunities to spread. Furthermore, many young children who were born during the pandemic may not have been exposed to RSV previously, leading to a larger susceptible population. This can result in a more widespread and intense RSV season.
The symptoms of RSV in children can vary from mild to severe. It's important to recognize these signs to seek timely medical attention:
Symptoms typically worsen around days three to four and then gradually improve, taking about one to two weeks for complete recovery. However, for infants and children with underlying health issues, RSV can lead to serious complications like bronchiolitis (inflammation of the small airways in the lungs) and pneumonia (infection of the lungs).
While any child can contract RSV, certain groups are at a higher risk of developing severe illness:
Diagnosing RSV usually involves a combination of physical examination and symptom assessment. Doctors will listen to the child's lungs for abnormal sounds like wheezing. In some cases, especially when symptoms are severe or the child is at high risk, further tests may be recommended:
It's important to note that there is no specific antiviral medication for RSV. Treatment focuses on managing symptoms and preventing complications.
For most children with mild RSV, treatment involves supportive care at home:
Hospitalization may be necessary for children with severe symptoms, requiring:
Preventing RSV is key, especially for vulnerable children. Simple hygiene practices can make a big difference:
It is essential to consult a doctor if your child exhibits any of the following:
Do not send your child to school or daycare if they have a fever in the last 24 hours or if their cough is worsening, without consulting a doctor first. Your doctor can advise on the appropriate duration for keeping your child home to prevent further spread.
A: Yes, a child can get RSV multiple times throughout their life. Immunity after an infection is not long-lasting, and reinfection is common, though subsequent infections may be milder.
A: RSV shares many symptoms with the common cold and flu, making it difficult to distinguish based on symptoms alone. However, RSV can cause more severe respiratory illness, especially in infants and high-risk children. A COVID-19 test can help rule out that illness, but specific testing is needed to confirm RSV.
A: As of recent advancements, there are now vaccines available for older adults and for pregnant individuals to protect their newborns. For young children, particularly those at high risk, doctors may discuss other preventive measures like Palivizumab (Synagis), a monoclonal antibody injection, which can help prevent severe RSV illness in eligible infants and children.
A: Children are typically contagious for about 1 to 2 weeks. Some infants, especially those with weakened immune systems, may remain contagious for longer periods.
A: Palivizumab is a medication given as a monthly injection during RSV season to certain high-risk infants and children to help prevent severe RSV disease. It is not a vaccine but a monoclonal antibody that provides passive immunity. Eligibility is based on factors like prematurity and certain heart or lung conditions.

Understand the peripheral blood smear test for malaria diagnosis, its procedure, and what results mean for patients.
April 20, 2026

Discover how specialized staining techniques, like Giemsa, are crucial for accurately diagnosing Leishmaniasis, identifying the parasite, and guiding timely treatment. Understand this key diagnostic approach.
April 20, 2026

Understand the peripheral blood smear test for malaria diagnosis, its procedure, and why it's a vital tool in combating this disease.
April 20, 2026